Arterial properties in relation to genetic variation in α-adducin and the renin-angiotensin system in a White population

Journal of Human Hypertension

Volumn 23, Issue 1, 2009, Pages 55-64

  Seidlerova J ^a,b   Staessen, J A ^a,c   Nawrot, T ^a   Brand, E ^d   Brand Herrmann, S M ^e   Casamassima, N ^f   Citterio, L ^f   Hasenkamp, S ^d   Kuznetsova, T ^a   Li, Y ^g   Manunta, P ^f   Richart, T ^a,c   Struijker Boudier, H A ^h   Fagard, R ^a   Filipovsky J ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADDUCIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCINE; TRYPTOPHAN;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; ARTERY COMPLIANCE; ARTICLE; BRACHIAL ARTERY; CAROTID ARTERY; CAUCASIAN; ECHOGRAPHY; FAMILY; FEMALE; FEMORAL ARTERY; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA RENIN ACTIVITY; POPULATION RESEARCH; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSINOGEN; BELGIUM; BRACHIAL ARTERY; CALMODULIN-BINDING PROTEINS; CAROTID ARTERIES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FEMORAL ARTERY; HAPLOTYPES; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; YOUNG ADULT;

EID: 57849168496     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.113     Document Type: Article

References (26)

1. +-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 2004; 95: 1100-1108.
2. Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L et al. Hypertension-associated point mutations in the adducin a and b subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97: 2815-2822.
3. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism. Detection and impact on hypertension and related disorders. Hypertension 2005; 45: 331-340.
4. Staessen JA, Wang J-G, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 1629-1641.
5. Balkestein EJ, Wang J-G, Struijker-Boudier HAJ, Barlassina C, Bianchi G, Birkenhäger WH et al. Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens 2002; 20: 1551-1561.
6. Balkestein EJ, Staessen JA, Wang J-G, van der Heijden-Spek J, Van Bortel LM, Barlassina C et al. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 2001; 38: 1190-1197.
7. Li Y, Zagato L, Kuznetsova T, Tripodi G, Zerbini G, Richart T. Angiotensin-converting enzyme I/D and α-adducin Gly460Trp polymorphisms. From angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension 2007; 49: 1291-1297.
8. Kuznetsova T, Staessen JA, Kawecka-Jaszcz K, Babeanu S, Casiglia E, Filipovsky J et al. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit 2002; 7: 215-224.
9. Zebekakis PE, Nawrot T, Thijs L, Balkestein EJ, van der Heijden-Spek J, Van Bortel LM et al. Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens 2005; 23 1839-1846.
10. Seidlerova J, Staessen JA, Maillard M, Nawrot T, Zhang H, Bochud M et al. Association between arterial properties and renal sodium handling in a general population. Hypertension 2006; 48: 609-615.
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(Suppl 1): S5-S10.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
13. Van Bortel LM, Balkestein EJ, van der Heijden-Spek J, Vanmolkot FH, Staessen JA, Kragten JA et al. Non-invasive assessment of local arterial pulse pressure: Comparison of applanation tonometry and echo-tracking. J Hypertens 2001; 19: 1037-1044.
14. Hoeks AP, Reneman RS. Biophysical principles of vascular diagnosis. J Clin Ultrasound 1995; 23: 71-79.
15. Kool MJF, van Merode T, Reneman RS, Hoeks APG, Struijker-Boudier HA, Van Bortel LM. Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res 1994; 28: 610-614.
16. Staessen JA, Wang J-G, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19: 1349-1358.
17. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34: 423-429.
18. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 279-292.
19. Abdollahi MR, Lewis RM, Gaunt TR, Cumming DVE, Rodriguez S, Rose-Zerilli M et al. Quantitated transcript haplotypes (QTH) of AGTR1, reduced abundance of mRNA haplotypes containing 1166C (rs5186:A>C), and relevance to metabolic syndrome traits.Hum Mutat 2007; 28: 365-373.
20. Orlov SN, Adragna NC, Adarichev VA, Hamet P. Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. Am J Physiol 1999; 276: C511-C536.
21. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786-1797.
22. Brand E, Chatelain N, Paillard F, Tiret L, Visvikis S, Lathrop M et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Eur J Hum Genet 2002; 10: 715-723.
23. Kuznetsova T, Staessen JA, Reineke T, Olszanecka A, Ryabikov A, Tikhonoff V et al. Context-dependency of the relation between left ventricular mass and AGT gene variants. J Hum Hypertens 2005; 19: 155-163.
24. Resnick LM, Catanzaro D, Sealey JE, Laragh JH. Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system. Am J Hypertens 2004; 17: 203-208.
25. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869.
26. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.